 | • レポートコード：MRC2Q12-17359 • 出版社/出版日：QYResearch / 2022年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥710,500 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,421,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、末梢動脈疾患用医薬品コーティングバルーンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 末梢動脈疾患用医薬品コーティングバルーンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 末梢動脈疾患用医薬品コーティングバルーンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 末梢動脈疾患用医薬品コーティングバルーンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの末梢動脈疾患用医薬品コーティングバルーンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の末梢動脈疾患用医薬品コーティングバルーンの売上および2028年までの予測に焦点を当てています。 末梢動脈疾患用医薬品コーティングバルーンのグローバル主要企業には、Medtronic、Boston Scientific、BD、Philips、Aachen Resonanceなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 末梢動脈疾患用医薬品コーティングバルーン市場は、タイプとアプリケーションによって区分されます。世界の末梢動脈疾患用医薬品コーティングバルーン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 パクリタキセルコーティング、その他コーティング 【アプリケーション別セグメント】 病院、ASC、カテーテル検査室 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 末梢動脈疾患用医薬品コーティングバルーン製品概要 - タイプ別市場（パクリタキセルコーティング、その他コーティング） - アプリケーション別市場（病院、ASC、カテーテル検査室） - 調査の目的 ・エグゼクティブサマリー - 世界の末梢動脈疾患用医薬品コーティングバルーン販売量予測2017-2028 - 世界の末梢動脈疾患用医薬品コーティングバルーン売上予測2017-2028 - 末梢動脈疾患用医薬品コーティングバルーンの地域別販売量 - 末梢動脈疾患用医薬品コーティングバルーンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別末梢動脈疾患用医薬品コーティングバルーン販売量 - 主要メーカー別末梢動脈疾患用医薬品コーティングバルーン売上 - 主要メーカー別末梢動脈疾患用医薬品コーティングバルーン価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（パクリタキセルコーティング、その他コーティング） - 末梢動脈疾患用医薬品コーティングバルーンのタイプ別販売量 - 末梢動脈疾患用医薬品コーティングバルーンのタイプ別売上 - 末梢動脈疾患用医薬品コーティングバルーンのタイプ別価格 ・アプリケーション別市場規模（病院、ASC、カテーテル検査室） - 末梢動脈疾患用医薬品コーティングバルーンのアプリケーション別販売量 - 末梢動脈疾患用医薬品コーティングバルーンのアプリケーション別売上 - 末梢動脈疾患用医薬品コーティングバルーンのアプリケーション別価格 ・北米市場 - 北米の末梢動脈疾患用医薬品コーティングバルーン市場規模（タイプ別、アプリケーション別） - 主要国別の末梢動脈疾患用医薬品コーティングバルーン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの末梢動脈疾患用医薬品コーティングバルーン市場規模（タイプ別、アプリケーション別） - 主要国別の末梢動脈疾患用医薬品コーティングバルーン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の末梢動脈疾患用医薬品コーティングバルーン市場規模（タイプ別、アプリケーション別） - 主要国別の末梢動脈疾患用医薬品コーティングバルーン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の末梢動脈疾患用医薬品コーティングバルーン市場規模（タイプ別、アプリケーション別） - 主要国別の末梢動脈疾患用医薬品コーティングバルーン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの末梢動脈疾患用医薬品コーティングバルーン市場規模（タイプ別、アプリケーション別） - 主要国別の末梢動脈疾患用医薬品コーティングバルーン市場規模（トルコ、サウジアラビア） ・企業情報 Medtronic、Boston Scientific、BD、Philips、Aachen Resonance ・産業チェーン及び販売チャネル分析 - 末梢動脈疾患用医薬品コーティングバルーンの産業チェーン分析 - 末梢動脈疾患用医薬品コーティングバルーンの原材料 - 末梢動脈疾患用医薬品コーティングバルーンの生産プロセス - 末梢動脈疾患用医薬品コーティングバルーンの販売及びマーケティング - 末梢動脈疾患用医薬品コーティングバルーンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 末梢動脈疾患用医薬品コーティングバルーンの産業動向 - 末梢動脈疾患用医薬品コーティングバルーンのマーケットドライバー - 末梢動脈疾患用医薬品コーティングバルーンの課題 - 末梢動脈疾患用医薬品コーティングバルーンの阻害要因 ・主な調査結果 |
Drug-coated balloons (DCB), also referred to as drug-eluting balloons (DEB), were created as a way to reduce very high restenosis rates in peripheral vessels.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Drug-Coated Balloon for Peripheral Artery Diseases is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Drug-Coated Balloon for Peripheral Artery Diseases is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Drug-Coated Balloon for Peripheral Artery Diseases is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Drug-Coated Balloon for Peripheral Artery Diseases include Medtronic, Boston Scientific, BD, Philips and Aachen Resonance, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Drug-Coated Balloon for Peripheral Artery Diseases manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Drug-Coated Balloon for Peripheral Artery Diseases market. Further, it explains the major drivers and regional dynamics of the global Drug-Coated Balloon for Peripheral Artery Diseases market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Medtronic
Boston Scientific
BD
Philips
Aachen Resonance
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Drug-Coated Balloon for Peripheral Artery Diseases Segment by Type
Paclitaxel Coated
Other Coated
Drug-Coated Balloon for Peripheral Artery Diseases Segment by Application
Hospitals
ASCs
Catheterization Laboratory
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug-Coated Balloon for Peripheral Artery Diseases market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Drug-Coated Balloon for Peripheral Artery Diseases, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Drug-Coated Balloon for Peripheral Artery Diseases, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Drug-Coated Balloon for Peripheral Artery Diseases, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug-Coated Balloon for Peripheral Artery Diseases sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Drug-Coated Balloon for Peripheral Artery Diseases market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Drug-Coated Balloon for Peripheral Artery Diseases sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Medtronic, Boston Scientific, BD, Philips and Aachen Resonance, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Drug-Coated Balloon for Peripheral Artery Diseases in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Drug-Coated Balloon for Peripheral Artery Diseases manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug-Coated Balloon for Peripheral Artery Diseases sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Drug-Coated Balloon for Peripheral Artery Diseases Product Introduction
1.2 Market by Type
1.2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Paclitaxel Coated
1.2.3 Other Coated
1.3 Market by Application
1.3.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 ASCs
1.3.4 Catheterization Laboratory
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Estimates and Forecasts 2017-2028
2.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Estimates and Forecasts 2017-2028
2.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region
2.4.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2017-2022)
2.4.2 Global Sales Drug-Coated Balloon for Peripheral Artery Diseases by Region (2023-2028)
2.5 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region
2.5.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region (2017-2022)
2.5.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Manufacturers
3.1.1 Global Top Drug-Coated Balloon for Peripheral Artery Diseases Manufacturers by Sales (2017-2022)
3.1.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug-Coated Balloon for Peripheral Artery Diseases in 2021
3.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Manufacturers
3.2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Manufacturers (2017-2022)
3.2.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drug-Coated Balloon for Peripheral Artery Diseases Revenue in 2021
3.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type
4.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Historical Sales by Type (2017-2022)
4.1.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Forecasted Sales by Type (2023-2028)
4.1.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2017-2028)
4.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Type
4.2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Historical Revenue by Type (2017-2022)
4.2.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Type (2017-2028)
4.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Price by Type
4.3.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Price by Type (2017-2022)
4.3.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application
5.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Historical Sales by Application (2017-2022)
5.1.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Forecasted Sales by Application (2023-2028)
5.1.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2017-2028)
5.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Application
5.2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Historical Revenue by Application (2017-2022)
5.2.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Application (2017-2028)
5.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Price by Application
5.3.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Price by Application (2017-2022)
5.3.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type
6.1.1 North America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2017-2028)
6.1.2 North America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Type (2017-2028)
6.2 North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application
6.2.1 North America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2017-2028)
6.2.2 North America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Application (2017-2028)
6.3 North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country
6.3.1 North America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2017-2028)
6.3.2 North America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type
7.1.1 Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2017-2028)
7.1.2 Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Type (2017-2028)
7.2 Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application
7.2.1 Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2017-2028)
7.2.2 Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Application (2017-2028)
7.3 Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country
7.3.1 Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2017-2028)
7.3.2 Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type
8.1.1 Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2017-2028)
8.1.2 Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Type (2017-2028)
8.2 Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application
8.2.1 Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2017-2028)
8.2.2 Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Application (2017-2028)
8.3 Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Region
8.3.1 Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2017-2028)
8.3.2 Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type
9.1.1 Latin America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2017-2028)
9.1.2 Latin America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Type (2017-2028)
9.2 Latin America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application
9.2.1 Latin America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2017-2028)
9.2.2 Latin America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Application (2017-2028)
9.3 Latin America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country
9.3.1 Latin America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2017-2028)
9.3.2 Latin America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type
10.1.1 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Type (2017-2028)
10.2 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application
10.2.1 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Application (2017-2028)
10.3 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country
10.3.1 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Corporation Information
11.2.2 Boston Scientific Overview
11.2.3 Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boston Scientific Recent Developments
11.3 BD
11.3.1 BD Corporation Information
11.3.2 BD Overview
11.3.3 BD Drug-Coated Balloon for Peripheral Artery Diseases Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BD Drug-Coated Balloon for Peripheral Artery Diseases Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BD Recent Developments
11.4 Philips
11.4.1 Philips Corporation Information
11.4.2 Philips Overview
11.4.3 Philips Drug-Coated Balloon for Peripheral Artery Diseases Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Philips Drug-Coated Balloon for Peripheral Artery Diseases Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Philips Recent Developments
11.5 Aachen Resonance
11.5.1 Aachen Resonance Corporation Information
11.5.2 Aachen Resonance Overview
11.5.3 Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aachen Resonance Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drug-Coated Balloon for Peripheral Artery Diseases Industry Chain Analysis
12.2 Drug-Coated Balloon for Peripheral Artery Diseases Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug-Coated Balloon for Peripheral Artery Diseases Production Mode & Process
12.4 Drug-Coated Balloon for Peripheral Artery Diseases Sales and Marketing
12.4.1 Drug-Coated Balloon for Peripheral Artery Diseases Sales Channels
12.4.2 Drug-Coated Balloon for Peripheral Artery Diseases Distributors
12.5 Drug-Coated Balloon for Peripheral Artery Diseases Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drug-Coated Balloon for Peripheral Artery Diseases Industry Trends
13.2 Drug-Coated Balloon for Peripheral Artery Diseases Market Drivers
13.3 Drug-Coated Balloon for Peripheral Artery Diseases Market Challenges
13.4 Drug-Coated Balloon for Peripheral Artery Diseases Market Restraints
14 Key Findings in The Global Drug-Coated Balloon for Peripheral Artery Diseases Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
| 【末梢動脈疾患用医薬品コーティングバルーンについて】 末梢動脈疾患用医薬品コーティングバルーンは、末梢動脈疾患の治療に用いられる医療機器の一つで、バルーンカテーテルの一種です。この装置は、末梢動脈における血流障害を改善するために、非侵襲的かつ効果的な治療手段を提供します。本稿では、医薬品コーティングバルーンの定義、特徴、種類、用途、関連技術について詳しく解説いたします。 まず、医薬品コーティングバルーンの定義について説明します。医薬品コーティングバルーンは、バルーンの表面に特定の医薬品をコーティングしたもので、血管内に挿入され、拡張することにより血管を広げます。同時にコーティングされた医薬品が放出され、血管壁に直接作用することで、再狭窄のリスクを軽減することが期待されます。このように、単なる機械的な拡張だけではなく、薬理学的な作用も付加されることで、治療効果が高まります。 次に、医薬品コーティングバルーンの特徴についてお話しします。主な特徴としては、まず、薬剤放出の速さと持続性があります。コーティングに用いられる薬剤は通常、血管内皮細胞の増殖を抑制する効果があり、これにより再狭窄を防ぎます。また、特に重要なのは、コーティングバルーンが血管内に十分に薬物を届け、効果的に浸透させる能力です。このため、コーティング技術や薬剤の選定が非常に重要です。 さらに、医薬品コーティングバルーンは、従来のバルーンに比べて再狭窄率が低いという利点があります。特に、ステントと比較して、外科的なインプラントを伴わないため、血管の自然な状態を最大限に維持することができます。この点で、患者にとっての侵襲性が低く、合併症のリスクも軽減される可能性があります。 種類については、医薬品コーティングバルーンにはさまざまなタイプがあり、使用される薬剤の種類やコーティング技術によって分類されることが一般的です。主な薬剤には、シクロスポリンや薬剤化された抗炎症剤、抗プロリフェラティブ剤などがあり、各種のバルーン製品に応じて選択されます。コーティング方法においては、溶媒法、スプレー法、浸漬法など異なる技術が用いられ、製品ごとに特異な特性を持たせています。 用途としては、医薬品コーティングバルーンは主に末梢動脈疾患、特に下肢の動脈における狭窄性病変の治療に用いられます。これらの疾患は、動脈硬化などの影響で、血流が阻害される状態を指し、しばしば痛みや歩行障害を引き起こします。医薬品コーティングバルーンは、その優れた治療効果により、このような症例の治療において非常に有望な選択肢とされています。 また、従来のバルーン治療が効果的でない場合や再発時には、医薬品コーティングバルーンが選ばれることが多くなっています。実際に、臨床試験でもその効果が示されており、医療界からも注目されています。 関連技術としては、バルーンの設計や製造プロセス、さらにコーティング技術の進化があります。新しい材料の導入や、製造過程における精密化が進むことで、医薬品コーティングバルーンはより高い性能を持つ製品へと進化しています。また、血管内イメージング技術や、ナビゲーションシステムとの組み合わせによって、さらに効果的な治療が可能となっています。 最近では、個別化医療の観点から、患者一人ひとりの特性に応じて最適な治療が行えるよう、医薬品コーティングバルーンの応用も進化しています。これにより、患者の病態に応じて選定される薬剤やコーティング方法が多様化することで、治療効果が一層向上することが期待されています。 最後に、医薬品コーティングバルーンは、将来の血管治療の新たな可能性を象徴する存在であり、その研究開発は今後も続くことでしょう。新しい知見や技術が進化する中で、末梢動脈疾患治療における医薬品コーティングバルーンの役割はますます重要になると考えられます。今後の動向に注目し、患者に対して最善の治療法が提供されるよう、医療技術の向上が期待されます。 |